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Abstract  
BACKGROUND: Physiotherapy is an essential for the treatment of patients with chronic respiratory non-
inflammatory diseases especially for chronic obstructive pulmonary disease (COPD). 
AIM: To assess the effect of six months physiotherapy (PT) program on functional status in patients with COPD. 
МАTERIAL AND METHODS: The patients were divided into two groups according to the severity of the disease. 
Group A included 33 patients (mean age 68.6 ± 7.3; GOLD II – III stages). Group B included 32 patients (mean 
age 71.7 ± 6.9; GOLD I –II). They were referred to supervised PT program performed three times weekly for a half 
a year. All the patients were on standard medical care. At entry and after PT, six minutes walking test (6 MWT), 
Borg scale and modified Medical Research Council (mMRC) scale were assessed.  
RESULTS: Significant changes in 6 MWT (р < 0.001) and mMRC scale (р < 0.001) were found after applied 
physical therapy program in patients of group A. Exertional dyspnoea decreased significantly in patients with 
group A (р < 0.001). Positive changes were found in physical tolerance in the patients of group B (р < 0.001). 
CONCLUSIONS: The present study revealed the positive effect of six months physiotherapy in physical tolerance 
and dyspnoea in patients with COPD at different stages of the disease. 
 
 
 
 
Introduction 
 
Chronic obstructive pulmonary disease 
(COPD) is a common disease that affects the 
bronchopulmonary system. The progressive course of 
COPD is connected with the development of extra 
pulmonary complications such as cardiovascular 
diseases, skeletal muscle dysfunction, osteoporosis, 
cachexy, anxiety and depression. Thus deteriorates 
the health related quality of life and increases physical 
intolerance in patients with COPD. Pulmonary 
rehabilitation is a multidisciplinary program for treating 
patients with chronic pulmonary diseases. It is 
individually tailored, and its principal goal is to 
optimize physical and social status of the patients. 
Physiotherapy (PT) is the milestone in the structure of 
pulmonary rehabilitation. PT increases exercise 
tolerance, mobility in daily activities, reduces 
breathlessness, improves quality of life by applying 
various therapeutic exercises and breathing 
techniques [1-3]. 
The study aims to assess the effect of the 
same six months physiotherapy protocol on functional 
status in patients with COPD at different stages of the 
disease. 
 
 
Material and Methods 
 
The patients with COPD were divided into two 
groups according to the stage of the disease. Group A 
consists of 11 males and 22 females with proven 
clinical and functional chronic obstructive pulmonary 
disease, mean age 68.6 ± 7.3. Patients are in the 
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second to third stages of COPD according to GOLD 
(2014) and mean disease duration 7.3 years (5 to 12 
years). Concomitant diseases include arterial 
hypertension (70%), ischemic heart disease (49%), 
diabetes type II (6%) and degenerative joint diseases 
including osteoporosis (9%). The number of 
concomitant diseases is on average 3.3 per person. 
Group B included four males and 28 women with 
COPD at an average age of 71.7 ± 6.9. Patients are in 
the first to second stages according to GOLD (2014) 
with mean disease duration 2.5 years (1.5 to 4 years). 
Concomitant diseases are a hypertonic disease 
(53%), ischemic heart disease (31%), type II diabetes 
mellitus (9%), and degenerative joint diseases 
including osteoporosis (6%). The number of 
concomitant diseases is an average of 3.0 per person. 
The following including criteria for patients in 
the both groups were used: patients with clinical and 
paraclinical proven COPD, according to spirometric 
data; patients from both sexes, smokers and non-
smokers; stable haemodynamic parameters; 
motivation and positive attitude while performing 
therapeutic exercises for a long time; informed written 
consent to participate in this research. 
Exclusion criteria were: severe acute 
respiratory and cardiovascular failure; history of 
cerebrovascular accidents and/or myocardial 
infarction, within the past six months, and fractures of 
the lower extremities in the last three months; 
neurological and joint diseases, which can interfere 
implementation of the physiotherapeutic sessions and 
tests (such as rheumatoid arthritis, Parkinson's 
disease, polyneuropathy); decompensate diabetes 
mellitus; expressed cognitive impairments. The 
patients with COPD from the two groups were treated 
with adequate medication (bronchodilators, 
mucolytics, expectorants) and individual additional 
treatment for the patients with co-morbidities. 
In the two groups, physiotherapy was 
performed according to our methodology developed 
for COPD patients in outpatient settings. The PT 
protocol was applied for six months, divided into three 
training periods - initial, main and final. The initial 
period includes the first 4-6 weeks and aimed patient’s 
adaptation to the regular physical activity and creating 
habits for proper breathing. The main period lasts four 
months, aimed at achieving optimal therapeutic 
influence (improvement of the vital capacity, 
endurance and strength of the respiratory muscles, 
reduce symptoms, an increase of fitness level, 
prevention of the complications, normalization of the 
cardiorespiratory function).  
The final period covers the last 3-4 weeks, 
and in PT session’s air baths, sun baths, water 
procedures and general physical strengthening and 
endurance training were included. For these reasons, 
a healing camp is being carried out in the early 
autumn months with a full-time activity program with 
moderate intensity and climatotherapy at the sea or in 
the mountain's balneology resorts, around 800 m 
average altitude. In the outpatient conditions, 
physiotherapeutic group sessions were conducted 
three times weekly with duration of 30 min at the 
beginning of the study, to one hour at the end, 
including aerobic exercises with low intensity (walking, 
slow running, cycling); entertaining and low intensity 
games; hiking; equilibrium exercises; resistance 
exercises; callisthenic exercises for all over fit in 
adults and the elderly with COPD.  
The specific PT techniques included: teaching 
in correct physiological breathing, training in 
diaphragmatic breathing, breathing in the lower, 
middle, and upper portions of the lungs, breathing 
through the nose and mouth at rest and during 
exercises. Aiming to reduce of bronchoconstriction 
and dyspnoea we included exercises in different 
specific respiratory postures sitting on a chair; 
inhalations; slow breathing with an emphasis on the 
exhalation; self-massage of the intercostal muscles 
and the neck.  
To increase the strength and endurance of 
the respiratory muscles we used in the PT sessions 
pushed, forced exhalation exercises; "coughing" 
exercises; exhale by pronouncing the syllables”, 
exercise for prolonged inhalation and short-time 
exhale, combined with gymnastic exercises for the 
chest, abdominal and back muscles.  
The following indicators, before and after the 
experimental period were monitored: six-minutes 
walking test, Borg Dyspnoea Scale and mMRC scale 
[4-6]. 
 
 
Results 
 
Regarding the demographic and 
anthropometric data, (sex, age, height, and weight) 
both groups of patients with COPD were almost 
identical. During the experimental period, the patients 
in the group A and the group B (with different severity 
of COPD and varying degrees of functional 
impairments) were treated by our physiotherapeutic 
methodology, and objective information about the 
changes in the monitored parameters were collected. 
The obtained study results were statistically analyzed 
using SPSS version19.0, and a paired sample t-test 
was applied. The significance level was set up at p 
<0.05 
The results of the group A, concerning 
physical tolerance and the dyspnoea levels during 
daily or physical activities, are presented in table one. 
At the beginning of the experiment the patients in the 
group A, had worse indicators of the functional status 
due to the severity of the disease. 
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Таble 1: Changes in the mean values of physical tolerance and 
levels of dyspnoea before and after physical therapy in group 
A 
 Measurement Test 
n =33 
X1 ± SD X2 ± SD X1– X2 t p 
Six minutes walking test (m) 351.3 ± 74.3 389.3 ± 72.4 38. 0 6.12 < 0.001 
Borg Scale (points) 4.5 ± 2.4 3.6 ± 2.0 - 0.9 5.72 < 0.01 
mMRC Scale (points) 1.8 ± 1.1 1.6 ± 1.0 - 0.2 1.98 0.05 
X1 ± SD - mean values and standard deviation at the start of the study; X2 ± SD - mean 
values and standard deviation at the end of the study; t-criteria of Students t-test; ** p 
<0.01 - significant difference compared with baseline values;*** p <0.001 - significant 
difference compared with baseline values.  
 
Increasing walking distance with an average 
of 38 m was observed. The reported difference 
showed statistically significant improvement (p < 
0.001). We believe that the improved tolerance to 
physical exercises was because specific exercises for 
the lower extremities were included in PT sessions. 
Similar results in patients at different stages of COPD 
have also been observed by some other authors [7-
11]. 
Considering the importance and prevalence of 
the breathlessness as the main limiting factor for 
physical activity in patients with COPD, patients were 
examined using two additional special tests. One of 
the tests was used to evaluate the dyspnoea in 
performing daily activities (mMRC Dyspnoea Scale), 
and the other was used to assess the dyspnoea 
during physical exertion (Borg Dyspnoea Scale). 
According to the final research results for the patients 
in group A, a tendency for reducing the occurrence 
and severity of dyspnoea was reported. The changes 
were improved, based on the Borg Scale - 0.9 points 
(p < 0.01), as well as the mMRC Scale - an average of 
0.2 points (p < 0.05). We believe that the reducing the 
feeling of breathlessness was associated with the 
following: improved bronchial patency and mechanics 
of breathing through learning, training and improving 
diaphragmatic breathing, exhaling through pursed lips, 
and exhaling while making whistling and buzzing 
sounds (producing a low-pitched sound resembling 
the bee humming). A diaphragmatic breathing 
technique is more economical for the body, but it is 
more difficult for women, who constitute the majority 
of the studied contingent. It became clear that 
decrease of this indicator has been achieved as a 
result of applying the physiotherapeutic methodology, 
where the special breathing exercises took place [12].  
A baseline dyspnoea reduction of 0.3 points 
and improvement of the patient’s subjective status 
after a six-month unsupervised home 
physiotherapeutic program which included physical 
exercises for strength and endurance was found [13]. 
Clini E et al (2008) established higher levels of 
improvement in the feeling of shortness of breath in 
daily living after at least 15 physiotherapeutic 
sessions, applied to patients with all stages of COPD 
[14]. The obtained results from mMRC Scale 
decreased on average by 1.1 points, compared to the 
baseline levels, which had been on average 2.7 
points. At the beginning of their study, the baseline 
status of the monitored patients showed a significantly 
pronounced dyspnoea when compared to our patients 
(1.8 points) probably due to including patients from 
the fourth COPD stage in their study.  
The changes occurring in the physical 
tolerance and the feeling of breathlessness in group B 
before and after physiotherapy are presented on 
Table two.  
Таble 2: Changes in the mean values of physical tolerance and 
level of dyspnoea before and after physical therapy in group B 
 Measurement Test 
n = 32 
X1 ± SD X2 ± SD X1– X2 t p 
Six minutes walking test (m) 426,6  57,3 455,9 71,7 29,3 4,43 < 0,001 
Borg Scale (points) 0,53 ± 1,16 2,38 ± 1,80 1,85 5,72 < 0,001 
mMRC Scale (points) 0,59 ± 0,61 0,63 ± 0,61 0,04 0,57 > 0,05 
X1 ± SD - mean values and standard deviation at the start of the study; X2 ± SD - mean 
values and standard deviation at the end of the study; t-criteria of Students t-test; *** p < 
0.001 - significant difference compared with baseline values.  
 
The changes in 6MWT after the 
physiotherapeutic treatment were statistically 
significant (p < 0.001). The improvement in the 
walking distance for six minutes was on average 29 
m, which was with 10 m less than the results of group 
A (38 m). According to the Enright P, (1998) formula, 
the referent value for healthy adults of the same age, 
height and weight, as the patients with COPD in the 
group B, was 452 m. After the initial examination the 
data obtained (427 m) represented 94% of the 
normative values, and at the end of the study, it 
corresponded to the normative value (456 m). 
Moreover, better physical tolerance was probably due 
to the lower degree of bronchial obstruction in the 
group B.  
In the group B, increased dyspnoea levels 
were found with 1.85 points, according to the Borg 
Scale, tested after the 6MWT. However, after the final 
examination, dyspnoea levels (2.4 points) showed a 
lower degree (0-4 points), according to the ten-point 
Borg Scale. 
 
 
Discussion 
 
Our findings suggested that the results 
obtained in the group B would be favourable about the 
perceived breathlessness because the dyspnoea was 
kept at a relatively low level throughout the monitored 
period [15-19]. 
The baseline level of dyspnoea while 
performing daily living activities was almost 
unchanged, which was a favourable result, 
considering the nature and expected prognosis of 
COPD. Breathlessness in daily lifestyle in the group B 
was less pronounced (between 0-1 points), according 
to the five-point mMRC Scale, which indicated that the 
breathing disturbances occurred only after intense 
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physical exertion, such as fast walking speed on a flat 
or a light slope surface, or climbing more than three 
floors of stairs. The dyspnoea did not adversely affect 
physical tolerance, objectified by a six minutes walk 
test. A lot of researchers recommend the Borg scale 
to assess the effect of performing physical therapy 
[20-25]. 
 In conclusion, the present study revealed the 
positive effect of the same six months physiotherapy 
protocol on physical tolerance, the level of dyspnoea 
after physical exertion and during daily living activities 
in patients with COPD at the different stages of the 
disease and especially for the patients with more 
pronounced disease severity which is very important 
for PT practice. 
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